| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/22/2010 | WO2010030119A3 Fluorescent silica nanoparticles for detecting lymph node and the identification method of lymph node using thereof |
| 07/22/2010 | WO2009109588A3 Mixed ligand core/shell iron oxide nanoparticles for inflammation imaging |
| 07/22/2010 | US20100186098 Transgenic animal models of parkinson's disease |
| 07/22/2010 | US20100186097 Cell-based rna interference and related methods and compositions |
| 07/22/2010 | US20100183735 Method for inducing selectively suppressed immune response to transplanted tissue or cells |
| 07/22/2010 | US20100183636 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 07/22/2010 | US20100183522 Contrast agents |
| 07/22/2010 | US20100183521 Methods of detecting and treating colon disorders |
| 07/22/2010 | US20100183520 Netrin-1 as a biomarker of injury and disease |
| 07/22/2010 | US20100183519 Topical Poloxamer Formulations for Enhancing Microvascular Flow: Compositions and Uses Thereof |
| 07/22/2010 | US20100183518 Vaccine Against Group A Beta Hemolytic Streptococcus And Respective Process For Obtaining Thereof |
| 07/22/2010 | US20100183517 Peptidomimetic Inhibitors Of PSMA, Compounds Comprising Them, And Methods Of Use |
| 07/22/2010 | US20100183516 Self coupling recombinant antibody fusion proteins |
| 07/22/2010 | US20100183515 Compositions and methods for treating the vertebral column |
| 07/22/2010 | US20100183514 Molecules involved in regulation of osteoblast activity and osteoclast activity, and methods of use thereof |
| 07/22/2010 | US20100183513 N-(methyl) -1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's |
| 07/22/2010 | US20100183510 EphB RECEPTOR-BINDING PEPTIDES |
| 07/22/2010 | US20100183504 Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics |
| 07/22/2010 | US20100183503 Myocardial perfusion imaging methods and compositions |
| 07/22/2010 | CA2749797A1 Compound having tumor-resident property |
| 07/21/2010 | EP2209000A2 Detection, monitoring and treatment of cancer |
| 07/21/2010 | EP2207571A1 Quantum theory-based continuous precision nmr/mri: method and apparatus |
| 07/21/2010 | EP0748228B1 powder FOR THE PROVOCATION OF AIR PASSAGE NARROWING AND/OR THE INDUCTION OF SPUTUM |
| 07/21/2010 | CN101781356A Arginine hybrid cell-penetrating peptide and application thereof |
| 07/21/2010 | CN101780285A Thermal-enhanced polymer nano ultrasonic imaging micelle loaded with liquid fluorocarbon and preparation method thereof |
| 07/21/2010 | CN101780284A Magnetic molecular targeted ultrasound contrast agent microsphere and preparation method thereof |
| 07/20/2010 | US7758875 Vaccine |
| 07/20/2010 | US7758874 Genetic engineered polypeptides; bactericide |
| 07/20/2010 | US7758869 Immunization of animal; mixture with solid phase lipid; oral administering |
| 07/20/2010 | US7758861 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions |
| 07/20/2010 | CA2322487C Novel prodrugs for phosphorus-containing compounds |
| 07/15/2010 | WO2010080804A1 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators |
| 07/15/2010 | WO2010079201A1 Contrast media compositions |
| 07/15/2010 | WO2010079156A1 Non-invasive tools for detecting vulnerable atherosclerotic plaques |
| 07/15/2010 | WO2010079079A2 PDGF-Rβ BINDERS |
| 07/15/2010 | WO2010078942A2 Dye solution |
| 07/15/2010 | WO2010058361A3 Method for the production of scaffolds for tissue engineering, comprising the use of an anchoring unit, and scaffold produced therewith |
| 07/15/2010 | WO2010056889A3 Use of an antibody and a rare-earth based crystal |
| 07/15/2010 | WO2009156743A3 Magnetic microbubbles, methods of preparing them and their uses |
| 07/15/2010 | US20100179401 Integrated receiver for continuous analyte sensor |
| 07/15/2010 | US20100178346 Disc augmentation with hyaluronic acid |
| 07/15/2010 | US20100178253 Peptide imaging agents |
| 07/15/2010 | US20100178252 Products and methods for disclosing conditions in the oral cavity |
| 07/15/2010 | US20100178251 Dual-Sensitizer-Containing Luminescent Compounds, Conjugates, and Uses Thereof |
| 07/15/2010 | US20100178250 Method of Local Delivery of Bioactive and Diagnostic Agents Using Magnetizable Bone Cement |
| 07/15/2010 | US20100178249 Imaging medium comprising lactate and hyperpolarised 13c-pyruvate |
| 07/15/2010 | US20100178247 Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer |
| 07/15/2010 | US20100178246 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting psma |
| 07/15/2010 | US20100178243 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 07/15/2010 | CA2749047A1 Non-invasive tools for detecting vulnerable atherosclerotic plaques |
| 07/15/2010 | CA2747673A1 Dye solution |
| 07/14/2010 | EP2206787A2 Peptide-enhanced transfections |
| 07/14/2010 | EP2206726A1 Non-invasive tools for detecting vulnerable atherosclerotic plaques |
| 07/14/2010 | EP2205553A1 Contrast agents |
| 07/14/2010 | EP2205284A2 Novel method for preparing nanoparticles covered with a gem-bisphosphonate stabilising layer coupled to hydrophilic biodistribution ligands |
| 07/14/2010 | EP2205282A2 Polymer nanoparticles coated by magnetic metal oxide and uses thereof |
| 07/14/2010 | CN101773676A Liquid fluorocarbon supported polymer nanometer ultrasonic imaging micelle and preparation method thereof |
| 07/14/2010 | CN101773675A Liquid fluorocarbon supported polymer nanometer ultrasonic imaging vesicle and preparation method thereof |
| 07/14/2010 | CN101773674A Gastrointestinal motivity marker capsule |
| 07/14/2010 | CN101773673A Medical sterilization ultrasonic coupling agent and preparation method thereof |
| 07/14/2010 | CN101301223B Rat chills and fever approach behavior determinator |
| 07/14/2010 | CN101032625B Constructing method of model of lacking of Langerhans cells of small rat skin |
| 07/13/2010 | US7754941 Transgenic mammal comprising pancreatic ER kinase gene (PERK) for identifying modulators for prevention and treatment of nervous system disorders |
| 07/13/2010 | US7754732 such as 4-Oxo-2-phenyl-1,3,8-triaza-spiro[4,5]dec-1-ene-8-carboxylic acid{1-7-methyl-1H-indazol-5-yl methyl)-2-[1,4]bipiperidinyl-1'-yl-2-oxo-ethyl}-amide, used as antagonists of calcitonin gene-related peptide receptors; used in the therapy of headaches and respiratory system disorders |
| 07/13/2010 | US7754459 having an amino acid sequence which has a functional NAD+ binding domain and no PARP zinc finger sequence motifs |
| 07/13/2010 | US7754190 Neurophysiological information from quantitative electroencephalogram (QEEG) is used as the independent variable and medication response is analyzed as the dependent variable; observing the connection between neurophysiology and the clinical outcome of treatment; pharmakinetics |
| 07/13/2010 | US7754189 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 07/13/2010 | CA2448303C Biologically active methylene blue derivatives |
| 07/13/2010 | CA2356533C Inhibitors of the bitter taste response |
| 07/08/2010 | WO2010076334A2 Intraoperative diagnosis of primary tumors and secondary tumors or metastases |
| 07/08/2010 | WO2010076237A2 Nanoparticle contrast agents for diagnostic imaging |
| 07/08/2010 | WO2009114776A3 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
| 07/08/2010 | US20100175140 Leucine-rich repeat kinase (LRRK2) drosophila model for parkinson's disease: wildtype1 (WT1) and G2019S mutant flies |
| 07/08/2010 | US20100172844 Albumin binding molecules and uses thereof |
| 07/08/2010 | US20100172843 Nanoparticulate probe for in vivo monitoring of tissue oxygenation |
| 07/08/2010 | US20100172841 Viable near-infrared fluorochrome labeled cells and methods of making and using the same |
| 07/08/2010 | US20100172840 Preparation of carbon nanotubes with lanthanoid catalysts |
| 07/08/2010 | US20100172839 Method and system for evaluating gastrointestinal motility |
| 07/08/2010 | US20100172838 Endometrial biomarkers |
| 07/08/2010 | US20100172837 MN Gene and Protein |
| 07/08/2010 | US20100172834 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
| 07/08/2010 | US20100172833 Methods and compositions for diagnosing hepatocellular carcinoma |
| 07/08/2010 | US20100172832 Diagnosis and treatment of malignant neoplasms |
| 07/08/2010 | US20100172830 Extraembryonic Tissue cells and method of use thereof |
| 07/08/2010 | US20100172829 Enhanced carriers for the delivery of microparticles to bodily tissues and fluids |
| 07/08/2010 | CA2748408A1 Nanoparticle contrast agents for diagnostic imaging |
| 07/07/2010 | EP2204662A1 Device for hyperpolarising and dissolving solid material for NMR analyses |
| 07/07/2010 | EP2204454A1 Predicting treatment response in cancer subjects |
| 07/07/2010 | EP2204194A2 Probe for a hair cell, and labelling method for a hair cell using the probe for a hair cell |
| 07/07/2010 | EP2203190A1 Contrast agents |
| 07/07/2010 | EP2203189A1 Contrast agents |
| 07/07/2010 | EP2203188A1 Biomarker to measure drug efficacy in enteropathic disease |
| 07/07/2010 | EP1470218B1 Corona-virus-like particles comprising functionally deleted genomes |
| 07/07/2010 | CN101768210A Tumor targeting polypeptide and preparation method thereof |
| 07/07/2010 | CN101766826A Preparation method of ferroferric oxide nanoparticles with liver targeting function |
| 07/07/2010 | CN101766825A Method for detecting activity of bone extracts of animals |
| 07/07/2010 | CN101766506A Animal intravenous infusion administration device and use thereof in large-scale medicine evaluation experiment |
| 07/06/2010 | US7750041 Using antihyperplastic agent; diffusion through capillaries; imaging veins, arteries; side effect reduction; antitumor agents |
| 07/06/2010 | US7749718 Method for raising or isolating an antibody to DCRS5 |
| 07/06/2010 | US7749499 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics |